Some studies have suggested that elevated serum ALT is merely a result of more extensive myocardial injury but not an indicator of liver damage [13, 27], whereas others have concluded that ALT elevation is a biomarker of liver damage, primarily caused by heart failure in patients with AMI [9, 32]. The gene discussed is GPT; the disease is heart failure.